Rallybio Corporation Common Stock (RLYB) is a publicly traded Healthcare sector company. As of May 21, 2026, RLYB trades at $14.43 with a market cap of $74.70M and a P/E ratio of -5.06. RLYB moved +2.18% today. Year to date, RLYB is +168.41%; over the trailing twelve months it is +427.04%. Its 52-week range spans $1.76 to $15.31. Rallies surfaces RLYB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
RLYB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. RLYB recently traded at $14.43. Market cap is $74.70M. P/E ratio is -5.06. Revenue is $858.00K.
| Metric | Value |
|---|---|
| Price | $14.43 |
| Market Cap | $74.70M |
| P/E Ratio | -5.06 |
| EPS | $-2.84 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.31 |
| 52-Week Low | $1.76 |
| Volume | 86 |
| Avg Volume | 0 |
| Revenue (TTM) | $858.00K |
| Net Income | $-7.82M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $858.00K | $-8.98M | $-1.59 |
| 2024 | $600.00K | $-57.77M | $-1.33 |
| 2023 | $0 | $-74.56M | $-1.84 |
| 2022 | $0 | $-66.65M | $-2.09 |
RLYB analyst coverage data. Average price target: $0.00.